HERA W10 Diagnostic Ultrasound System, HERA W9 Diagnostic Ultrasound System

Samsung Medison Co., LTD · K220043 · 2022-04-05

HERA W10 Diagnostic Ultrasound System, HERA W9 Diagnostic Ultrasound System is an AI-enabled medical device from Samsung Medison Co., LTD, listed by FDA (510(k), K220043) with a decision date of 2022-04-05. Review panel: Radiology.

FDA submission numberK220043
Pathway510(k)
CompanySamsung Medison Co., LTD
Review panel (specialty)Radiology
FDA decision date2022-04-05
DecisionSubstantially Equivalent
Product codeIYN
ClassificationSystem, Imaging, Pulsed Doppler, Ultrasonic
Device class2
Regulation number892.1550
Review time (calendar days)90
Applicant countryKR

Official FDA database record · FDA AI-enabled device list

More devices from Samsung Medison Co., LTD · All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.